EuroQol PhD Network

My third PhD paper, a psychometric validation of the Indonesian version of the FACIT-COST questionnaire for subjective financial toxicity, has been published in Health and Quality of Life Outcomes. Read it for free here! https://lnkd.in/e4jy5vPM You can also check out my other papers: - A systematic review and meta-analysis on financial toxicity and health-related quality of life: https://lnkd.in/dYkRsrg6 - A qualitative exploration of how Indonesian patients with cancer experience and cope with financial toxicity: https://lnkd.in/dH7CHbZZ

🌟 Major Milestone in Health Economics Research 🌟 I am happy to share that our latest work, titled "Systematic review reveals that EQ-5D minimally important differences decrease with increasing baseline score and may vary with treatment type", has officially been published in the Journal of Clinical Epidemiology and is now available as open access, thanks to the support from the EuroQol Research Foundation. You can access it here: https://lnkd.in/gr4bXk67. This publication serves as a pivotal step forward in health economics research, addressing frequent questions we receive from academics, healthcare professionals, and industry partners, such as: "What is the MID for EQ-5D index and EQ VAS score?" "How can it be used to determine the clinical importance of a treatment effect?" In this paper, our team conducted a comprehensive evidence synthesis on anchor-based minimal important differences (MIDs) for the EQ-5D instruments, a widely-used, generic measure of health-related quality of life, with two adult versions: EQ-5D-3L and EQ-5D-5L. We pooled 210 MID estimates from 47 studies, broken down into: - 122 estimates for EQ-5D-3L index scores - 51 estimates for EQ-5D-5L index scores - 47 estimates for EQ VAS 💡 Key Implications and Practical Applications: Our review introduces a user-friendly method using formulas and an established reference table for EQ-5D users to determine MIDs tailored to their specific contexts. This approach simplifies the process compared to the complex protocols often required in the literature. NOTE: Our latest revision made some minor updates where the nonlinear polynomial model outperformed other models in predicting the MIDs of improved scores. The formulas have also been updated accordingly (Refer to the third image), or you can derive the MID scores from Table 4 in the paper. For health deterioration, we recommend using the overall average MIDs (mean: -0.02 for EQ-5D-3L, -0.04 for EQ-5D-5L, and -6.5 for EQ VAS) to interpret changes in health status. 📊 This work advances the understanding and use of EQ-5D data, making it more accessible and actionable for healthcare decision-making. It provides a valuable benchmark for interpreting changes in health outcomes and enhances the precision of health evaluations. Lastly, a special thank you to my incredible mentors Nan Luo, Michael Herdman, and my colleagues Le Ann Chen and Jing Ying Cheng for their invaluable support. 🔬🤝 #HealthEconomics #Research #EQ5D #MID #QualityOfLife #Healthcare

📣 OPEN now - 18th Call for Proposals by the EuroQol Working Groups ⏰ Deadline: 20 Oct 2024, 23:59 CEST 📃 Download the Call for Proposals doc: https://bit.ly/3MAXL3L Best of luck to all applicants! #EQ5D #ResearchCall #HealthcareResearch

I am happy to share our recent publication: "Socio-economic, patient, and hospital determinants for the utilization of peripheral nerve blocks in total joint arthroplasty". I am particularly proud of this work, as it was the result of a great exchange at the department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai, New York. Link: https://lnkd.in/ebhuSZPB. We studied sources of variation in the use of peripheral nerve blocks in hip and knee arthroplasty among Medicare patients. We found that clinical (e.g., the indication for arthroplasty) and hospital characteristics explained most variation in block use. Socioeconomic and demographic characteristics played a limited role. In knee arthroplasty, blocks were also associated with reduced complications and shorter length of stay. Our results, especially in knee arthroplasty patients, suggest a need for more standardized use of peripheral nerve blocks. We hope that this exchange leads to future collaborations between our departments! Many thanks to my co-authors for their invaluable contributions: Jashvant Poeran, Hanish Kodali, Gouke J. Bonsel, Brocha Stern.

⏳ Time is running out! Our webinar 'Mapping EQ-5D-5L in dementia & translating EQ-5D-3L into Krio' takes place NEXT WEEK (8 August 2024, 14:00 CEST). 💻 Register in time: https://bit.ly/3XBMSFX The webinar will feature research from Hannah Hussain (The University of Sheffield) and Daniel Youkee (King's College London). They will also answer questions from Bernhard Michalowsky (German Center for Neurodegenerative Diseases (DZNE)) and Sarah Derrett (Pākehā) (University of Otago). #EuroQol #HealthEconomics #HealthcareResearch

Excited to share our latest publication in Gastroenterology where we modelled the “Long-term cost-effectiveness of case-finding and mass-screening for coeliac disease in children” using a point-of-care test (POCT) in primary pediatric care. POCTs for coeliac disease are affordable, accurate, and easy to use, making them ideal for screening in primary care to identify children needing further examination. Compared to current practice, where diagnoses are often missed or delayed by years, case-finding and screening with a POCT are likely highly cost-effective alternatives. It was a pleasure to collaborate on this study with various departments and organizations. Special thanks to Elske van den Akker- van Marle for the fantastic supervision, and to my co-authors Caroline Meijer, Lucy Smit Floris van Overveld, Edna Keeney, Howard Thom, and Maria Luisa Mearin for their invaluable contributions. I’ve learned so much from you! #Research #Healthcare #CoeliacDisease #PrimaryCare #CostEffectiveness #Screening #POCT Leiden University Medical Center Nederlandse Coeliakie Vereniging Article link: https://lnkd.in/eKqiS6uC